Yeonghak Bang
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: March 27, 2021
Correction to: Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis.
Journal: Targeted oncology
Published: March 19, 2021
Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
Journal: Cancer management and research
Published: March 01, 2021
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis.
Journal: Journal of cancer research and clinical oncology
Published: February 11, 2021
Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 16, 2020
Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma.
Journal: Cancer medicine
Published: August 23, 2020
Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective study.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 04, 2020
Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis.
Journal: Liver cancer
Published: March 09, 2020
Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 04, 2020
Rivaroxaban Versus Low-molecular-weight Heparin for Venous Thromboembolism in Advanced Upper Gastrointestinal Tract and Hepatopancreatobiliary Cancer.
Journal: In vivo (Athens, Greece)
Published: December 24, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026